Cancer Biomarker Market: Global Market Size, Industry Growth, Future Prospects, Opportunities and Forecast 2019-2025

1. Orion Market Research Cancer Biomarker Market, by Biomarker Type (Genetic Biomarker, Protein Biomarker), By Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer), By Application (Drug Discovery & Development, Diagnosis, Risk Assessment, Prognostics), By Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, Bioinformatics) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025 ------------------------------------------------------------------------------------ Email: info@omrglobal.com Phone: +91 780-304-0404, +1 646-755-7667 Protein biomarker is widely used in the cancer diagnosis due to various benefits such as the creation of powerful bioinformatics software, spectral libraries, and peptide databases. These benefits are creating new opportunities for developing protein biomarkers for the diagnosis, prognosis of disease and prediction of response to a therapeutic treatment. The role of biomarkers extends all the aspects of drug discovery and development. The research of protein biomarkers includes glycosylation and phosphorylation, as it provides a clear indication of treatment with the time frame and drugs impacted on a disease. Hence, it’s a decisive pathway for signaling and activation, often give insight into disease states.

2. Browse the full report description of "Cancer Biomarker Market, by Biomarker Type (Genetic Biomarker, Protein Biomarker), By Cancer Type (Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer), By Application (Drug Discovery & Development, Diagnosis, Risk Assessment, Prognostics), By Profiling Technology (Omics Technology, Immunoassays, Cytogenetics, Bioinformatics) - Global Trends, Size, Share, Growth, Industry Analysis and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/cancer-biomarkers-market Growing research related to cancer biomarkers The researches that are going presently has turned to the proteomics, for developing new biomarkers. These latest researches have improved the accuracy of the biomarkers as early detection of the diseases enables to provide better treatment. Presently, scientists are also focusing on the gene expression for detecting the results of the therapy process. Recently, the National Cancer Institute (NCI) sponsored Trial Assigning Individualized Option for treatment (Rx), or TAILORx. The National Cancer Institute in March 2016 has earmarked $5.5 million for funding for the establishment of laboratories with an aim to advance research on biomarkers and biomarker assays for various cancers such as of the prostate, lung, breast, and genitourinary organs. The continuous interest of the government and major companies in the research and developing new technology for cancer biomarker is motivating market growth. The increasing trend towards personalized medicines The increasing adoption of personalized medicines for cancer is augmenting the growth of the cancer biomarker market. Personalized medicine has the potential to modify therapy with the best response and highest safety margin to ensure better patient care. By enabling these medicines, each patient to receive earlier diagnoses, risk assessments, and optimal treatments. The personalized medicine holds promise for improving health care while lowering costs which is expected to be a positive indicator for market growth. As per to the Personalized Medicine Coalition (PMC), around 42% of all compounds and around 73% of oncology compounds in the pipeline have the potential to be included in personalized medicines. Visit here to know more about Cancer Biomarker Market study https://www.omrglobal.com/industry- reports/cancer-biomarkers-market The cancer biomarker companies closely doubled their R&D investment in personalized medicine over the past five years and suppose to increase their investment in the near future. Moreover, estimates of disease susceptibility or disease prognosis can be improved by combining genomic test results with knowledge about various factors such as age, lifestyle, or tumor size. This is promising for predicting disease susceptibility, disease prognosis, or drug response of an individual patient. For device and drug manufacturers, personalized medicine provides an opportunity to develop agents that are targeted to patient groups that do not respond to medications as intended and for whom the traditional health systems have otherwise failed.

3. Cancer Biomarker Market- Segmentation By Biomarker Type •Genetic Biomarker •Protein Biomarker By Cancer Type •Lung Cancer •Prostate Cancer •Breast Cancer •Colorectal Cancer •Cervical Cancer By Application •Drug Discovery and Development •Diagnosis •Risk Assessment •Prognostics By Profiling Technology •Omics Technology •Immunoassays •Cytogenetics •Bioinformatics To know more information, please request a free report sample https://www.omrglobal.com/request- sample/cancer-biomarkers-market Cancer biomarker Market– Region North America •US •Canada Europe •Germany

4. •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •India •Japan •Rest of Asia-Pacific Rest of the World •Middle East & Africa •Latin America About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Cancer Biomarkers Market